Rani Therapeutics Appoints PricewaterhouseCoopers as New Auditor
Ticker: RANI · Form: 8-K · Filed: Apr 9, 2025 · CIK: 1856725
| Field | Detail |
|---|---|
| Company | Rani Therapeutics Holdings, Inc. (RANI) |
| Form Type | 8-K |
| Filed Date | Apr 9, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: auditor-change, accounting
TL;DR
Rani Therapeutics switches auditors to PwC, effective April 7, 2025.
AI Summary
Rani Therapeutics Holdings, Inc. announced on April 7, 2025, a change in its certifying accountant. The company has appointed PricewaterhouseCoopers LLP as its new independent registered public accounting firm, replacing BDO USA, LLP. This change is effective immediately.
Why It Matters
A change in auditors can signal shifts in financial reporting scrutiny or strategic direction for a company.
Risk Assessment
Risk Level: low — This filing reports a routine administrative change in the company's auditor, which typically carries low inherent risk.
Key Players & Entities
- Rani Therapeutics Holdings, Inc. (company) — Registrant
- PricewaterhouseCoopers LLP (company) — New Certifying Accountant
- BDO USA, LLP (company) — Former Certifying Accountant
- April 07, 2025 (date) — Effective Date of Change
FAQ
Who is Rani Therapeutics Holdings, Inc.'s new independent registered public accounting firm?
Rani Therapeutics Holdings, Inc. has appointed PricewaterhouseCoopers LLP as its new independent registered public accounting firm.
Who was Rani Therapeutics Holdings, Inc.'s previous independent registered public accounting firm?
Rani Therapeutics Holdings, Inc.'s previous independent registered public accounting firm was BDO USA, LLP.
When was the change in certifying accountant effective for Rani Therapeutics Holdings, Inc.?
The change in certifying accountant for Rani Therapeutics Holdings, Inc. was effective as of April 07, 2025.
Did BDO USA, LLP resign or was it dismissed by Rani Therapeutics Holdings, Inc.?
The filing does not specify the reason for the change, only that PricewaterhouseCoopers LLP has been appointed and BDO USA, LLP is no longer the certifying accountant.
What is the primary business of Rani Therapeutics Holdings, Inc.?
Rani Therapeutics Holdings, Inc. is in the Pharmaceutical Preparations industry, SIC code 2834.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 9, 2025 regarding Rani Therapeutics Holdings, Inc. (RANI).